GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » Minority Interest

Navana Pharmaceuticals (DHA:NAVANAPHAR) Minority Interest : BDT0.00 Mil (As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Navana Pharmaceuticals's minority interest for the quarter that ended in . 20 was BDT0.00 Mil.


Navana Pharmaceuticals Minority Interest Historical Data

The historical data trend for Navana Pharmaceuticals's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navana Pharmaceuticals Minority Interest Chart

Navana Pharmaceuticals Annual Data
Trend
Minority Interest

Navana Pharmaceuticals Semi-Annual Data
Minority Interest

Navana Pharmaceuticals Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.


Navana Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213
Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines